SBIR-STTR Award

Development Of Placebo Marijuana Cigarettes
Award last edited on: 1/30/14

Sponsored Program
SBIR
Awarding Agency
NIH : NIDA
Total Award Amount
$837,373
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Ram Murty

Company Information

Murty Pharmaceuticals Inc

518 Codell Drive
Lexington, KY 40509
   (859) 266-2446
   info@mpirx.com
   www.mpirx.com
Location: Single
Congr. District: 06
County: Fayette

Phase I

Contract Number: N43DA007708-000
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2000
Phase I Amount
$98,749
During the past several years there has been a steady increase in the abuse of marijuana among young adults. The major psychoactive component of marijuana that causes its abuse is delta-9-tetrahydrocannabinol (THC). As a result marijuana addiction has been the subject of a number of basic and clinical research programs directed toward understanding the mechanism of the addictive processes and the health hazard associated with its abuse. The common form of marijuana abuse is by smoking. Due to the non-availability of placebo or control marijuana cigarettes with natural marijuana flavors, attempts will be made to develop methodologies to produce marijuana with no or lowest level of THC, and produce placebo marijuana cigarettes with natural flavors for research during the SBIR Phase I contract. In addition, an attempt will also be made to evaluate the feasibility of producing marijuana cigarettes of different strengths with natural flavors

Phase II

Contract Number: N44DA017708-000
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2001
(last award dollars: 2002)
Phase II Amount
$738,624

___(NOTE: Note: no official Abstract exists of this Phase II projects. Abstract is modified by idi from relevant Phase I data. The specific Phase II work statement and objectives may differ)___ During the past several years there has been a steady increase in the abuse of marijuana among young adults. The major psychoactive component of marijuana that causes its abuse is delta-9-tetrahydrocannabinol (THC). As a result marijuana addiction has been the subject of a number of basic and clinical research programs directed toward understanding the mechanism of the addictive processes and the health hazard associated with its abuse. The common form of marijuana abuse is by smoking. Due to the non-availability of placebo or control marijuana cigarettes with natural marijuana flavors, attempts will be made to develop methodologies to produce marijuana with no or lowest level of THC, and produce placebo marijuana cigarettes with natural flavors for research during the SBIR Phase I contract. In addition, an attempt will also be made to evaluate the feasibility of producing marijuana cigarettes of different strengths with natural flavors